The Beta Cell Responsiveness to Glucose-Dependent Insulinotropic Polypeptide (GIP) With and Without Sulfonylurea in Patients With Type 2 Diabetes - Related Studies

The Beta Cell Responsiveness to Glucose-Dependent Insulinotropic Polypeptide (GIP) With and Without Sulfonylurea in Patients With Type 2 Diabetes

This study has been completed.

Study NCT00321321. Last updated on October 1, 2008. Information provided by University Hospital, Gentofte, Copenhagen

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Diabetes Mellitus, Type 2

2	Additional conditions recognized in this trial
		Diabetes Mellitus

3	More general conditions related to this trial
		Endocrine System Diseases
		Glucose Metabolism Disorders
		Metabolic Diseases

4	Interventions listed in this trial
		Sulfonylurea

5	Additional drug interventions recognized in this trial
		Gastric Inhibitory Polypeptide

6	More general drug interventions related to this trial
		Gastrointestinal Agents
		Hormones
		Hormones, Hormone Substitutes, and Hormone Antagonists
		Incretins
		Pharmacologic Actions
		Physiological Effects of Drugs
		Therapeutic Uses

7	Sponsors listed in this trial
		University Hospital, Gentofte, Copenhagen